74 related articles for article (PubMed ID: 2788866)
1. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
Rubin LG; Voulalas D; Carmody L
Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
[TBL] [Abstract][Full Text] [Related]
3. [Immunogenicity and tolerability of Haemophilus b-tetanus protein conjugate (PRP-T) in children with sickle cell anemia].
de Montalembert M; Bégué P; Fritzell B; Houmeau P
Arch Fr Pediatr; 1993 Dec; 50(10):863-6. PubMed ID: 8053763
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
[TBL] [Abstract][Full Text] [Related]
5. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
[No Abstract] [Full Text] [Related]
6. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type b immunization of children with sickle cell diseases.
Frank AL; Labotka RJ; Rao S; Frisone LR; McVerry PH; Samuelson JS; Maurer H; Yogev R
Pediatrics; 1988 Oct; 82(4):571-5. PubMed ID: 3262857
[TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
9. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Shapiro ED; Berg AT
Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
Käyhty H; Karanko V; Peltola H; Mäkelä PH
Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
13. Haemophilus B polysaccharide vaccine. Antibody kinetics in 17- to 71-month-old children.
Ramsey KP; Popejoy LA; Jesse SW; Gonzales-Torres I
Am J Dis Child; 1989 Jan; 143(1):28-30. PubMed ID: 2910043
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
Peltola H; Käyhty H; Virtanen M; Mäkelä PH
N Engl J Med; 1984 Jun; 310(24):1561-6. PubMed ID: 6610125
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
Lenoir AA; Granoff PD; Granoff DM
Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
[TBL] [Abstract][Full Text] [Related]
20. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
